I
I-O Urology
Forefront technology for urologic at home care
About I-O Urology
I-O Urology operates in the healthcare technology sector, specializing in remote patient monitoring systems for urology. The company serves urologists and their patients, offering a device and mobile app called the CarePath System. This system replaces traditional uroflows and subjective voiding diaries with a more convenient and accurate method of data collection. By providing reliable, objective data every time a patient voids, the CarePath System enhances diagnostic confidence and improves patient compliance. The business model revolves around selling the CarePath System to healthcare providers, who then use it to monitor their patients remotely. Revenue is generated through the sale of the devices and potentially through subscription fees for the accompanying mobile app. The market for I-O Urology includes urology clinics, hospitals, and individual practitioners looking to improve diagnostic accuracy and patient care.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2020
- Headquarters
- Knoxville, United States
- Employees
- 17
- Open positions
- None listed
- Dealroom signal
- 45.0/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Health Diagnostics, Hard Tech, urinary, remote health monitoring
- Business model
- Manufacturing, SaaS
- Client focus
- b2b, b2c
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | Mar 2024 | $0 | — | Undisclosed | ↗ |
| EARLY VC✓Equity / VC | Jan 2024 | $16M | $64M | LaunchTN · Solas BioVentures · Jumpstart Capital | ↗ |
Growth signals
Latest recorded traffic for I-O Urology is 370 monthly website visits, up 236.4% over the last three months. I-O Urology's team grew 13.3% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
LaunchTN
Solas BioVentures
Jumpstart Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about I-O Urology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See I-O Urology’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.